Abstract: This invention relates to a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, a kit for performing the method, and furthermore to isolated nucleotide sequences being complementary to one or more mutations of the CFTR gene. According to a first aspect of the invention there is provided a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, including the steps of providing one or more nucleic acid sequences, fully complementary to one or more segments of the CFTR gene, wherein the one or more nucleic acid sequences correspond to the mutation to be identified; providing a biological sample of an individual to be tested for CF; isolating nucleic acids from the biological sample; and testing the biological sample for the presence of one or more of the nucleic acid sequences using a suitable detection method.

Abstract: This invention relates to a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, a kit for performing the method, and furthermore to isolated nucleotide sequences being complementary to one or more mutations of the CFTR gene. According to a first aspect of the invention there is provided a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, including the steps of providing one or more nucleic acid sequences, fully complementary to one or more segments of the CFTR gene, wherein the one or more nucleic acid sequences correspond to the mutation to be identified; providing a biological sample of an individual to be tested for CF; isolating nucleic acids from the biological sample; and testing the biological sample for the presence of one or more of the nucleic acid sequences using a suitable detection method.

Abstract: This invention relates to a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, a kit for performing the method, and furthermore to isolated nucleotide sequences being complementary to one or more mutations of the CFTR gene. According to a first aspect of the invention there is provided a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, including the steps of providing one or more nucleic acid sequences, fully complementary to one or more segments of the CFTR gene, wherein the one or more nucleic acid sequences correspond to the mutation to be identified; providing a biological sample of an individual to be tested for CF; isolating nucleic acids from the biological sample; and testing the biological sample for the presence of one or more of the nucleic acid sequences using a suitable detection method.

Abstract: This invention relates to a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, a kit for performing said method, and furthermore to isolated nucleotide sequences being complementary to one or more mutations of the CFTR gene. According to a first aspect of the invention there is provided a method of identifying mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, including the steps of providing one or more nucleic acid sequences, fully complementary to one or more segments of the CFTR gene, wherein the said one or more nucleic acid sequences correspond to the mutation to be identified; providing a biological sample of an individual to be tested for CF; isolating nucleic acids from the biological sample; and testing the biological sample for the presence of one or more of the nucleic acid sequences using a suitable detection method.

Abstract: A bleaching assistant in the form of granulated particles for use in or with a washing and bleaching composition is provided which comprises:(a) 50-85% by weight of a bleaching activator for percompounds selected from the group consisting of N-acyl and O-acyl compounds and carbonic acid esters;(b) 2-25% by weight of a stabilizing agent for percompounds e.g. organic phosphonic acids or ethylenediaminetetraacetate;(c) 7-30% by weight of a nonionic surface-active compound having a melting point of at least 35.degree. C.

Abstract: Detergent formulations are granulated commercially by spray drying a slurry of the formulation. There is now proposed a method in which the components in powder form are granulated with a binder in a substantially horizontal annular rotating bed. The binder may be released by the action of the rotating bed.

Abstract: The disclosure relates to the protection of solid precursors in powder detergent compositions using a hydrogen peroxide bleach system. The finely divided precursor is formed, with a carrier material, into a composite particle which is then coated. The coated particle gives good dispersion of the precursor in the wash liquor.

Abstract: Enzyme granules, particularly for detergent compositions, are prepared having a granule core of solid material carrying an enzyme and a solid coating of plasticized resin free of the enzyme. The plasticized resin can be dextrin or sodium lignosulphonate containing a plasticizer such as glucose, sucrose urea, glycerol or ethylene glycol. The granules are made by spraying the enzyme-containing core with a concentrated aqueous solution of the plasticized resin.